Plan-les-Ouates
Switzerland
14
2024-07-11
The entities that hold a legal rights for patent applications filed by inventor CHOLLET Andre:
Andre CHOLLET from Plan-les-Ouates, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAGONISTS
#2 | 2023-07-20ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
#3 | 2023-03-30PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAGONISTS
#4 | 2021-02-18Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists
#5 | 2020-09-10Oral formulations of pyrrolidine derivatives
#6 | 2018-11-01Oral formulations of pyrrolidine derivatives
#7 | 2018-08-02Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists
#8 | 2017-11-09Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same
#9 | 2017-08-24Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
#10 | 2017-03-09ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
#11 | 2016-08-04PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1a RECEPTORS ANTAGONISTS
#12 | 2016-01-07Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same
#13 | 2015-06-18Oral formulations of pyrrolidine derivatives
#14 | 2015-03-12Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
1096667 ⎘